List of Neoprofen drug patents

Neoprofen is owned by Recordati Rare.

Neoprofen contains Ibuprofen Lysine.

Neoprofen has a total of 1 drug patent out of which 0 drug patents have expired.

Neoprofen was authorised for market use on 13 April, 2006.

Neoprofen is available in injectable;intravenous dosage forms.

The generics of Neoprofen are possible to be released after 02 March, 2032.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8415337 RECORDATI RARE Ibuprofen compositions and methods of making same
Mar, 2032

(9 years from now)

Drugs and Companies using IBUPROFEN LYSINE ingredient

Market Authorisation Date: 13 April, 2006

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of NEOPROFEN before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in